TNF and juvenile idiopathic arthritis: In the adalimumab and infliximab group, children with JIA-associated uveitis should be viewed differently, as it has been suggested that a higher dosage of anti-TNF drug is needed for penetration to obtain adequate drug levels in the eye [34].